Significance of pathogen identification for urinary tract infection and Helicobacter pylori infection in type 1 and type 2 diabetes mellitus patients
https://doi.org/10.51523/2708-6011.2023-20-2-05
Abstract
Objective. The aim of this study was to understand the significance of pathogen identification for Urinary tract infection and Helicobacter pylori infection in Diabetes Mellitus Type 1 and Diabetes Mellitus Type 2 patients.
Materials and methods. The study was conducted among 1749 patients with Type 1 and Type 2 Diabetes Mellitus. Using microbiological techniques, the frequency of urinary tract infection was identified and the aetiology and sensitivity of microorganisms to antibacterial drugs were assessed. Data collected on Helicobacter pylori infection were verified through PCR tests on biopsies collected from the gastric mucosa.
Results. The study showed that urinary tract infection has a high incidence rate with 58.3% of cases from Type 1 diabetes mellitus, and in 47.2% of cases from Type 2 diabetes. Pathogens such as Escherichia coli, Staphylococcus saprophyticus, Enterococcus faecalis and Klebsiella pneumoniae were the main causative agents of urinary tract infections. Helicobacter pylori infection was common in DM and more in cases of Type 2 Diabetes Mellitus at 27.1%, compared to cases in Type 1 Diabetes Mellitus at 22.8%. Also 5.9 % cases of Type 2 Diabetes Mellitus had combined Helicobacter pylori and urinary tract infections.
Conclusion. The study showed the significance in identification of urinary tract infections and Helicobacter pylori infections in patients with Type 1 and Type 2 Diabetes Mellitus, and especially significant for Type 2 Diabetes Mellitus patients.
About the Authors
M. G. Rusalenko
Republican Research Center for Radiation Medicine and Human Ecology
Belarus
Belarus
Mariya G. Rusalenko, Candidate of Medical Sciences, Associate Professor, Deputy Director
Gomel
M. Wisham
Republican Research Center for Radiation Medicine and Human Ecology
Belarus
Belarus
Mohamed Wisham, Endocrinologist
Gomel
T. V. Konovalova
Gomel City Clinical Polyclinic №11
Belarus
Belarus
Tatiana V. Konovalova, Endocrinologist
Gomel
L. V. Lischenko
Kalinkovichi Central District Hospital;
Gomel State Medical University
Belarus
Belarus
Lubov V. Lischenko, Endocrinologist
Kalinkovichi;
Clinical Resident
Gomel
I. G. Savasteeva
Republican Research Center for Radiation Medicine and Human Ecology
Belarus
Belarus
Irina G. Savasteeva, MD, Methodologist, Head of the Department of State Registration
Gomel
N. I. Shevchenko
Republican Research Center for Radiation Medicine and Human Ecology
Belarus
Belarus
Natalia I. Shevchenko, Candidate of Medical Sciences, Associate Professor, Head of the Cell Technology Laboratory
Gomel
References
1. Uitrakul S, Aksonnam K, Srivichai P, Wicheannarat S, Incomenoy S. The Incidence and Risk Factors of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Using SGLT2 Inhibitors: A Real-World Observational Study. Medicines. 2022;9(59). DOI: https://doi.org/10.3390/medicines9120059
2. Carrillo-Larco RM, Anza-Ramírez C, Saal-Zapata G, et al. Type 2 diabetes mellitus and antibiotic-resistant infections: a systematic review and meta-analysis. J Epidemiol Community Health. 2022;76:75-84. DOI: http://dx.doi.org/10.1136/jech-2020-216029
3. Alzahrani AM, Al Zaidi AA, Alzahrani SM, Binmahfouz SA, Farahat FM. Association between Type 2 diabetes mellitus and Helicobacter pylori infection among Saudi patients attending National Guard Primary Health Care Centers in the Western Region, 2018. J Family Community Med. 2020;27(1):8-14. DOI: https://doi.org/10.4103/jfcm.JFCM_142_19
4. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev. 1997;10(4):720-741. DOI: https://doi.org/10.1128/CMR.10.4.720
5. Jinhu C, Yuling X, Liying Zh, Huijuan M. The Association between Helicobacter pylori Infection and Glycated Hemoglobin A in Diabetes: A Meta-Analysis. Hindawi Journal of diabetic research. 2019. DOI: https://doi.org/10.1155/2019/3705264
6. Chung GE, Heo NJ, Park MJ, Chung SJ, Kang HY, Kang SJ. Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria. World J Gastroenterol. 2013;19. DOI: https://doi.org/10.3748/wjg.v19.i1.97
7. Xin S, Changzhou C, Qi J, Xueyang C, Chaohui Y. The efficacy of Helicobacter pylori eradication in diabetics and its effect on glycemic control: A systematic review and meta-analysis. National Library of Medicine. 2021;26(2):e12781. DOI: https://doi.org/10.1111/hel.12781
8. Lee JY, Kim N. Diagnosis of Helicobacter pylori by invasive test: histology. Ann Transl Med. 2015;3(1):10. DOI: https://doi.org/0.3978/j.issn.2305-5839.2014.11.03
9. Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E. The diagnosis of urinary tract infection: a systematic review. Dtsch Arztebl Int .2010 May;107(21):361-367. DOI: https://doi.org/10.3238/arztebl.2010.0361
10. Bissong ME, Fon PN, Tabe-Besong FO, Akenji TN. Asymptomatic bacteriuria in diabetes mellitus patients in Southwest Cameroon. Afr Health Sci. 2013 Sep;13(3):661-666. DOI: https://doi.org/10.4314/ahs.v13i3.20
11. Verrotti A, Prezioso G, Scattoni R, Chiarelli F. Autonomic neuropathy in diabetes mellitus. Front Endocrinol (Lausanne). 2014 Dec;1(5):205. DOI: https://doi.org/10.3389/fendo.2014.00205
12. Tesfaye G, Fitsum W, Dadi M, Zelalem T. Prevalence, Antimicrobial Susceptibility Pattern, and Associated Factors of Urinary Tract Infections among Adult Diabetic Patients at Metu Karl Heinz Referral Hospital, Southwest Ethiopia. International Journal of Microbiology. 2018, Nov 1;2018:7591259. DOI: https://doi.org/10.1155/2018/7591259
13. Yenehun Worku G, Belete Alamneh Y, Erku Abegaz W. Prevalence of Bacterial Urinary Tract Infection and Antimicrobial Susceptibility Patterns Among Diabetes Mellitus Patients Attending Zewditu Memorial Hospital, Addis Ababa, Ethiopia. Infect Drug Resist. 2021 Apr 15;14:1441-1454. DOI: https://doi.org/10.2147/IDR.S298176
14. Rusalenko MG, Shevchenko NI, Loginova OP. Urinary tract infections in diabetes: the significance of microbiological monitoring. General medicine. 2020;2(72):63-68.
15. Liu KS, Wong IO, Leung WK. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. World J Gastroenterol. 2016 Jan 21;22(3):1311-20. DOI: https://doi.org/10.3748/wjg.v22.i3.1311
16. Ghotaslou R, Leylabadlo HE, Asl YM. Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review. World J Methodol. 2015;5(3):164-174. DOI: https://doi.org/10.5662/wjm.v5.i3.164
17. López-Góngora S, Puig I, Calvet X, Villoria A, Baylina M, Muñoz N, et al. Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection. J Antimicrob Chemother. 2015;70(9):2447-2455. DOI: https://doi.org/10.1093/jac/dkv155
18. Maev IV, Andreev DN. Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy. Terapevticheskii Arkhiv. 2017;89(8):5-12. DOI: https://doi.org/10.17116/terarkh20178985-12
Review
For citations:
Rusalenko M.G., Wisham M., Konovalova T.V., Lischenko L.V., Savasteeva I.G., Shevchenko N.I. Significance of pathogen identification for urinary tract infection and Helicobacter pylori infection in type 1 and type 2 diabetes mellitus patients. Health and Ecology Issues. 2023;20(2):35-41. https://doi.org/10.51523/2708-6011.2023-20-2-05
Views: 361
Email this article 